Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Pharm Dev Technol ; 28(1): 143-151, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36648199

RESUMEN

Chewable gels present significant advantages over conventional dosage forms, despite their development is not comprehensively assessed. In this sense, six formulations, varying gelatine concentration, dose, and form of incorporation of praziquantel, were developed and characterized. The novelty of this approach focused not only on the development of the formulation itself but also on the incorporation of the drug in a nanoparticulated form. The obtained results for moisture content, water activity, pH, and drug content were within the expected values for this type of formulation. On the other hand, texture and disintegration parameters were influenced by the form of incorporation of praziquantel and the amount of gelatine added. Finally, in vitro dissolution of chewable gels showed significant differences with intermediate products, though the improved dissolution of the nanoparticulated drug was maintained. In conclusion, nanoparticulate drugs can be incorporated into these semisolid formulations and could be successfully applied to other low-aqueous solubility drugs.


Asunto(s)
Nanopartículas , Praziquantel , Solubilidad , Administración Oral , Alimentos , Agua , Geles
2.
Bioinformatics ; 36(3): 735-741, 2020 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-31504177

RESUMEN

MOTIVATION: Understanding the mechanisms of client protein interaction with Hsp70 chaperones is essential to analyze the complex dynamics in the context of normal or dysregulated metabolism. Because Hsp70 can bind millions of proteins, including key molecules involved in processes of stemness, tumorigenesis and survival, in silico prediction of Hsp70 interactions has great value in validating possible new clients. Currently, two algorithms are available to predict binding to DnaK-the bacterial Hsp70-but both are based on amino acid sequence and energy calculations of qualitative information-binders and non-binders. RESULTS: We introduce a new algorithm to identify Hsp70 binding sequences in proteins-ChaperISM-a position-independent scoring matrix trained on either qualitative or quantitative chemiluminescence data previously published, which were obtained from the interaction between DnaK and different ligands. Both versions of ChaperISM, qualitative or quantitative, resulted in an improved performance in comparison to other state-of-the-art chaperone binding predictors. AVAILABILITY AND IMPLEMENTATION: ChaperISM is implemented in Python version 3. The source code of ChaperISM is freely available for download at https://github.com/BioinfLab/ChaperISM. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.


Asunto(s)
Algoritmos , Programas Informáticos , Secuencia de Aminoácidos , Proteínas HSP70 de Choque Térmico , Unión Proteica
3.
Int Arch Occup Environ Health ; 94(3): 459-474, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33130969

RESUMEN

OBJECTIVE: The rapid transformation of labor markets has been accompanied by the belief of rising stress at work. However, empirical evidence on such trends based on reliable survey data is scarce. This study analyzes long-term trends in well-established measures of work stressors across Europe, as well as potential occupational differences. METHODS: We use repeated cross-sectional data of 15 European countries from waves 1995, 2000, 2005, 2010, and 2015 of the European Working Conditions Surveys. We apply three-way multilevel regressions (with employees nested in country-years, which are in turn nested in countries) to analyze trends in work stressors measured according to the demand-control and effort-reward imbalance models. Trends by occupational groups are also assessed. RESULTS: Our findings suggest that work stress generally increased from 1995 to 2015, and that the increase was mostly driven by psychological demands. People working in lower-skilled occupations had generally higher levels of job strain and effort-reward imbalance, as well as they tend to have a steeper increase in job strain than people working in higher-skilled occupations. Most of the change occurred from 1995 to 2005. CONCLUSION: Our results indicate that work stress has been on rise since 1995, specifically for people working in disadvantageous occupations. This directs the attention to the vulnerable position of the least skilled and also to the use of preventive measures to counteract some of the disadvantages experienced by this occupational group.


Asunto(s)
Estrés Laboral/epidemiología , Lugar de Trabajo/psicología , Adulto , Europa (Continente)/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Salud Laboral , Ocupaciones , Encuestas y Cuestionarios
4.
BMC Public Health ; 20(1): 1377, 2020 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-32912186

RESUMEN

BACKGROUND: Many studies have shown that work stressors have a negative impact on health. It is therefore important to gain an understanding of how work stressors can be reduced. Recent studies have shown that employees in countries with high investments into labour market policies less often report exposure to work stressors. Although these studies are indicative of an influence of the political level on work stressors, they are based on cross-sectional cross-country analyses where causal assumptions are problematic. The aim of this study is to extend the existing evidence by longitudinally testing whether changes in labour market policies are related to changes in work stressors. METHODS: We used comparative longitudinal survey data from the European Working Conditions Survey (27 countries; for the years 2005, 2010, 2015). The measurement of work stressors is based on two established work stress models: effort-reward imbalance (ERI) and job demand-control (job strain). To measure labour market policies, we used information on active (ALMP) and passive labour market policies (PLMP). After excluding persons with missing data, 64,659 participants were eligible for the ERI and 67,114 for job strain analyses. Estimation results are provided by three-way multilevel models (individuals, country-years, country), which allow us to estimate longitudinal and cross-country macro-effects. RESULTS: An increase in ALMP leads to a decrease of ERI. The analyses for the subcomponents 'effort' and 'reward' showed that mainly the 'reward' component is positively associated with ALMP. The association between ALMP and 'reward' shows that an increase in ALMP investments is related to an increase in rewards. Yet, no significant longitudinal associations between ALMP and job strain, and between PLMP and the work stressors, were observed. CONCLUSIONS: The study extends the current knowledge with longitudinal information by showing that an increase in ALMP is associated with an increase in rewards and a decrease of ERI. These longitudinal analyses may support a causal interpretation. The findings of this study have important policy implications. Our main result suggests that investments into ALMP can lead to better working conditions.


Asunto(s)
Análisis de Datos , Recompensa , Estudios Transversales , Europa (Continente) , Humanos , Satisfacción en el Trabajo , Estudios Longitudinales , Políticas , Estrés Psicológico/epidemiología , Encuestas y Cuestionarios
5.
BMC Public Health ; 20(1): 1572, 2020 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-33076886

RESUMEN

An amendment to this paper has been published and can be accessed via the original article.

6.
Drug Dev Ind Pharm ; 45(10): 1565-1589, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31282753

RESUMEN

Near-infrared spectroscopy (NIRS) is nowadays an established analytical technique in the pharmaceutical industry. The aim of this review is to present the progress of NIRS in providing useful information for pharmaceutical particle technology. NIR methods are now developed to characterize a wide variety of materials (active pharmaceutical ingredients, excipients, co-processed powders, and physical mixtures) and pharmaceutical dosage forms (conventional, modified drug release technologies, and phytomedicines). This review also provides a number of spectra to illustrate the fundamental understanding of NIRS which has been gained. The sampling that must occur prior to the acquisition of near-infrared spectra is also discussed, as well as developments in monitoring mixing, tableting, and coating. This review will be valuable for product formulation and process engineering specialists.


Asunto(s)
Preparaciones Farmacéuticas/química , Tecnología Farmacéutica/métodos , Química Farmacéutica/métodos , Industria Farmacéutica/métodos , Excipientes/química , Humanos , Polvos/química , Espectroscopía Infrarroja Corta/métodos
7.
AAPS PharmSciTech ; 20(8): 318, 2019 Oct 16.
Artículo en Inglés | MEDLINE | ID: mdl-31620905

RESUMEN

Praziquantel is a broad spectrum antihelmintic agent and represents the drug of choice for the treatment of schistosomiasis. However, its low aqueous solubility and strong bitter taste highly affect the bioavailability and compliance in pediatric patients. Thus, the purpose of this study was to develop a dry nanosuspension, by a combination of high-pressure homogenization and spray drying, intended for redispersion in a pleasant taste vehicle for extemporaneous use. Three formulations, varying stabilizers to drug ratio, were developed and characterized in terms of particle size distribution, crystallinity, morphology, in vitro dissolution, and sedimentation-redispersibility behavior. A significant reduction in particle size was achieved after the high-pressure homogenization process, and the nanoparticles were further microencapsulated by spray drying technique. The redispersed dried powders exhibited a conserved particle size distribution (in the nanometric range) and certain crystallinity extent, with satisfactory redispersion ability. Besides, the enhancement of the dissolution performance obtained after comminution was conserved, even after drying and redispersion of the extemporaneous powdered formulation. In conclusion, the developed nanoparticle-loaded powders comprise an interesting tool for the administration of praziquantel to preschool-age children.


Asunto(s)
Antihelmínticos/administración & dosificación , Nanopartículas/administración & dosificación , Praziquantel/administración & dosificación , Esquistosomiasis/tratamiento farmacológico , Niño , Composición de Medicamentos/métodos , Humanos , Tamaño de la Partícula , Polvos , Praziquantel/química
8.
Genet Mol Res ; 14(3): 10877-87, 2015 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-26400315

RESUMEN

Prostaglandin E2 (dinoprostone) is largely used for labor induction. However, one-third of patients do not respond to treatment. One cause of this poor response may be associated with changes in regulation of prostaglandin E receptors (EP1-4). In this study, we investigated EP mRNA expression in the uterine cervix and lower uterine segment myometrium for term births. Biopsies were obtained from women with successful (responders) and failed (non-responders) dinoprostone labor induction, while women that underwent spontaneous labor were included as controls. EP1 mRNA was upregulated in the cervical tissue of women who did not respond to dinoprostone induction. In addition, in the myometrium, significantly higher levels of EP3 mRNA were observed in women treated with dinoprostone, independent of their responsiveness. Dinoprostone-responders presented 3.6-fold higher levels of EP3 mRNA expression than the spontaneous labor group. Significantly higher levels of EP3 mRNA in the myometrium of the dinoprostone-treated group indicated that dinoprostone may regulate the EP3 gene on the transcriptional level. These results highlight the relationship between EP gene expression and delivery and indicate that understanding the regulation of prostaglandin E receptors may lead to improved labor induction.


Asunto(s)
Dinoprostona/uso terapéutico , Trabajo de Parto Inducido/métodos , ARN Mensajero/biosíntesis , Subtipo EP1 de Receptores de Prostaglandina E/genética , Contracción Uterina/efectos de los fármacos , Adulto , Estudios de Casos y Controles , Cuello del Útero/efectos de los fármacos , Cuello del Útero/metabolismo , Femenino , Expresión Génica/efectos de los fármacos , Humanos , Miometrio/efectos de los fármacos , Miometrio/metabolismo , Embarazo , ARN Mensajero/genética , Subtipo EP1 de Receptores de Prostaglandina E/biosíntesis , Subtipo EP2 de Receptores de Prostaglandina E/biosíntesis , Subtipo EP2 de Receptores de Prostaglandina E/genética , Subtipo EP3 de Receptores de Prostaglandina E/biosíntesis , Subtipo EP3 de Receptores de Prostaglandina E/genética , Insuficiencia del Tratamiento
9.
J Vet Pharmacol Ther ; 37(2): 105-24, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23980692

RESUMEN

An important frontier in the administration of therapeutic drugs to veterinary species is the use of different polymers as drug delivery platforms. The usefulness of polymers as platforms for the administration of pharmaceutical and agricultural agents has been clearly recognized in the recent decades. The chemical versatility of polymers and the wide range of developed controlled-release strategies enhance the possibilities for the formulation of active molecules. In particular, the veterinary area offers opportunities for the development of novel controlled-release drug delivery technologies adapted to livestock or companion animal health needs. In some cases, it also allows to improve profitability in meat production or to meet the safety criteria related to drug residues. A number of factors affect the selection of polymers and subsequent properties of the controlled-release drug delivery system. However, their selection also dictates the release kinetics of the drug from the delivery system. Such choices are therefore crucial as they affect the success and potential of the delivery system for achieving the therapeutic goals of the veterinarian. It is the intention of this review to give an overview of the most relevant polymers, which are used or have been tested as drug delivery release rate modifiers in the veterinary field. The article highlights some recent developments focusing on their advantages and applications and analyzes the future direction of the scientific and technological advancements in this area.


Asunto(s)
Polímeros/química , Drogas Veterinarias/administración & dosificación , Medicina Veterinaria/métodos , Animales , Formas de Dosificación
10.
Reprod Domest Anim ; 48(5): 844-9, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23691948

RESUMEN

The aim of the present study was to examine the role of oxytocin (OT) in the progesterone (P4) and prostaglandins (PGs) pathway to induce oocyte meiotic resumption. Cumulus-oocyte complexes were co-cultured with follicular hemisections for 15 h to determine the effects of different doses of OT or atosiban (ATO; oxytocin receptor antagonist) on oocyte meiotic resumption. In another experiment, we examined the effect of the interaction between P4, OT and PGs on the regulatory cascade of the oocyte meiotic resumption. Oxytocin at 1 µm was effective in inducing meiotic resumption in oocytes co-cultured with follicular cells (84.0%), not differing from the positive control group (74.4%). Atosiban inhibited in a dose-dependent manner the positive effect of OT on the meiotic resumption (27.6% metaphase I with 10 µm of ATO, which did not differ from the 25.5% of the negative control group). Furthermore, a third experiment showed that P4 was able to induce oocyte meiotic resumption, which was inhibited by ATO. However, the OT positive effect was not blocked by mifepristone (P4 antagonist), but was inhibited by indomethacin (a non-selective PTGS2 inhibitor). Collectively, these data suggest a sequential role of P4, OT and PGs in the induction of oocyte meiotic resumption.


Asunto(s)
Bovinos , Meiosis/efectos de los fármacos , Oocitos/efectos de los fármacos , Oxitocina/farmacología , Animales , Células Cultivadas , Relación Dosis-Respuesta a Droga , Femenino , Meiosis/fisiología , Oocitos/citología , Oocitos/fisiología , Oxitócicos/administración & dosificación , Oxitócicos/farmacología , Oxitocina/administración & dosificación , Tocolíticos/administración & dosificación , Tocolíticos/farmacología , Vasotocina/administración & dosificación , Vasotocina/análogos & derivados , Vasotocina/farmacología
11.
ScientificWorldJournal ; 2012: 876106, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22654644

RESUMEN

A highly porous optical-fiber cladding was developed for evanescent-wave fiber sensors, which contains sensor molecules, maintains guiding conditions in the optical fiber, and is suitable for sensing in aqueous environments. To make the cladding material (a poly(ethylene) glycol diacrylate (PEGDA) polymer) highly porous, a microsphere templating strategy was employed. The resulting pore network increases transport of the target analyte to the sensor molecules located in the cladding, which improves the sensor response time. This was demonstrated using fluorescein-based pH sensor molecules, which were covalently attached to the cladding material. Scanning electron microscopy was used to examine the structure of the templated polymer and the large network of interconnected pores. Fluorescence measurements showed a tenfold improvement in the response time for the templated polymer and a reliable pH response over a pH range of five to nine with an estimated accuracy of 0.08 pH units.


Asunto(s)
Tecnología de Fibra Óptica/métodos , Microesferas , Fibras Ópticas , Porosidad
12.
Radiother Oncol ; 166: 92-99, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34748855

RESUMEN

INTRODUCTION: Stereotactic ablative radiotherapy (SABR) has been shown to increase survival in oligometastatic disease, but local control of colorectal metastases remains poor. We aimed to identify potential predictive factors of SBRT response through a multicenter large retrospective database and to investigate the progression to the polymetastatic disease (PMD). MATERIAL AND METHODS: The study involved 23 centers, and was approved by the Ethical Committee (Prot. Negrar 2019-ZT). 1033 lung metastases were reported. Clinical and biological parameters were evaluated as predictive for freedom from local progression-free survival (FLP). Secondary end-point was the time to the polymetastatic conversion (tPMC). RESULTS: Two-year FLP was 75.4%. Two-year FLP for lesions treated with a BED < 00 Gy, 100-124 Gy, and ≥125 Gy was 76.1%, 70.6%, and 94% (p = 0.000). Two-year FLP for lesion measuring ≤10 mm, 10-20 mm, and >20 mm was 79.7%, 77.1%, and 66.6% (p = 0.027). At the multivariate analysis a BED ≥125 Gy significantly reduced the risk of local progression (HR 0.24, 95%CI 0.11-0.51; p = 0.000). Median tPMC was 26.8 months. Lesions treated with BED ≥125 Gy reported a significantly longer tPMC as compared to lower BED. The median tPMC for patients treated to 1, 2-3 or 4-5 simultaneous oligometastases was 28.5, 25.4, and 9.8 months (p = 0.035). CONCLUSION: The present is the largest series of lung colorectal metastases treated with SABR. The results support the use of SBRT in lung oligometastatic colorectal cancer patients as it might delay the transition to PMD or offer relatively long disease-free period in selected cases. Predictive factors were identified for treatment personalization.


Asunto(s)
Neoplasias Colorrectales , Neoplasias Pulmonares , Radiocirugia , Neoplasias del Recto , Neoplasias Colorrectales/patología , Humanos , Radiocirugia/métodos , Neoplasias del Recto/etiología , Estudios Retrospectivos
13.
Diabetes Metab ; 47(1): 101156, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-32387701

RESUMEN

AIMS: As diabetic retinopathy (DR) can occur even in well-controlled patients with type 2 diabetes (T2D), our study sought to determine whether it might be related to 'glucose memory' by evaluating patients' HbA1c over previous years and their skin autofluorescence (SAF). METHODS: In 334 patients with T2D and HbA1c levels≤8%, their available values of HbA1c from previous years were collected, and their SAF measured by an advanced glycation end-product (AGE) reader. Binary logistic regression analysis was then used to correlate DR with previously recorded HbA1c levels and to SAF, with adjustment for DR risk factors [age, gender, BMI, duration of diabetes, arterial hypertension, diabetic kidney disease (DKD), blood lipid levels and statin treatment]. RESULTS: Our patients were mostly men (58.4%) aged 63±10years, with a duration of diabetes of 13±10years and HbA1c=7.1±0.7%. Of these patients, 84 (25.1%) had DR, which was associated with longer duration of diabetes and greater prevalence of DKD. A total of 605 HbA1c values from previous years were collected for time periods -4±3 months (n=255), -16±4months (n=152), -30±4months (n=93) and -62±26 months (n=105). After adjustment, the association between DR and having an HbA1c higher than the median was significant only for the oldest previous HbA1c values: OR=6.75, 95% CI: 1.90-23.90. Moreover, SAF values were higher in those with DR [2.95±0.67 arbitrary units (AU)] vs 2.65±0.65 AU with no DR (P<0.01) and were also associated with the oldest previous HbA1c values (P<0.01). CONCLUSION: Our study found that 25.1% of our well-controlled T2D patients had DR, which was related to both their HbA1c levels from 5years prior to study admission and their SAF values, a marker of glucose memory.


Asunto(s)
Diabetes Mellitus Tipo 2 , Retinopatía Diabética , Anciano , Diabetes Mellitus Tipo 2/sangre , Retinopatía Diabética/epidemiología , Femenino , Hemoglobina Glucada/análisis , Humanos , Masculino , Persona de Mediana Edad
14.
Clin Transl Oncol ; 23(8): 1561-1570, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33570720

RESUMEN

PURPOSE: Radiosurgery (SRS) is an effective treatment option for brain metastases (BMs). Long-term results of the first worldwide experience with a mono-isocentric, non-coplanar, linac-based stereotactic technique in the treatment of multiple BMs are reported. METHODS: patients with multiple BMs, life expectancy > 3 months, and good performance status (≤ 2) were treated with simultaneous SRS with volumetric modulated arc technique. Data were retrospectively evaluated. RESULTS: 172 patients accounting for 1079 BMs were treated at our institution from 2017 to 2020. The median number of treated metastases was 4 (range 2-22). Primary tumor histology was: lung (44.8%), breast (32%), and melanoma (9.4%). The 2-year LPFS was 71.6%, respectively. A biological effective dose (BED) ≥ 51.3 Gy10 correlated with higher local control. Uncontrolled systemic disease and melanoma histology were independent prognostic factors correlated with decreased iPFS. Patients with > 10 BMs had a trend towards shorter iPFS (p = 0.055). 31 patients received multiple SRS courses (2-7) in case of intracranial progression. The median iOS was 22.4 months. Brainstem metastases and total PTV > 7.1 cc correlated with shorter iOS. The 1- and 2-year WBRT-free survival was 83.2% and 61.1%, respectively. CONCLUSION: Long-term results in a large patient population treated with a mono-isocentric, dedicated technique demonstrated its effectiveness and safety also in the case of multiple courses. The shortened treatment time and the possibility to safely spare healthy brain tissue allows the safe treatment of patients with a large number of metastases and to deliver multiple courses of SRS. In selected cases, the administration of WBRT can be delayed.


Asunto(s)
Neoplasias Encefálicas/radioterapia , Neoplasias Encefálicas/secundario , Irradiación Craneana/métodos , Radiocirugia/métodos , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias Encefálicas/mortalidad , Neoplasias de la Mama/patología , Estudios de Cohortes , Irradiación Craneana/efectos adversos , Irradiación Craneana/instrumentación , Femenino , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/patología , Masculino , Melanoma/radioterapia , Melanoma/secundario , Persona de Mediana Edad , Recurrencia Local de Neoplasia/radioterapia , Órganos en Riesgo/efectos de la radiación , Supervivencia sin Progresión , Traumatismos por Radiación/prevención & control , Radiocirugia/efectos adversos , Radiocirugia/instrumentación , Dosificación Radioterapéutica , Efectividad Biológica Relativa , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento
15.
Mater Sci Eng C Mater Biol Appl ; 93: 28-35, 2018 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-30274060

RESUMEN

Praziquantel (PZQ), an antihelmintic agent commonly administered to humans and cattle, has low aqueous solubility, which compromises its bioavailability and efficacy. The purpose of this study was to develop a new formulation, in order to improve PZQ dissolution rate. PZQ dispersions have been developed by high-pressure homogenization (HPH) using different stabilizers, selected upon PZQ saturation solubility. After the screening, two promising formulations were developed, combining poloxamer 188 with polyvinylpyrrolidone or maltodextrin. Characterization studies including particle size distribution, crystallinity, morphology, drug content, and in vitro dissolution profiles, were performed over selected formulations. The scanning electronic micrographs revealed that the morphology of suspended particles corresponded to elongated shapes, with an average particle size close to the micron range. X-ray powder diffractometry and differential scanning calorimetry results confirmed the drug crystallinity, before and after the HPH process. Besides, differential scanning calorimetry revealed the absence of interactions between PZQ and excipients. The dissolution rate of PZQ dispersions was significantly enhanced compared with raw PZQ, either in phosphate buffer or hydrochloric acid, mainly due to particle size reduction, thus improved saturation solubility.


Asunto(s)
Antihelmínticos/química , Poloxámero/química , Polisacáridos/química , Povidona/química , Praziquantel/química , Presión
16.
Dalton Trans ; 45(5): 2218-26, 2016 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-26584162

RESUMEN

The synthesis of 2,4,6-triphenylphosphinine has been revisited and a general protocol for the preparation of such low-coordinate phosphorus compounds in good to excellent yields could be established. This allows to investigate several aspects of the chemistry of 2,4,6-triarylphosphinine, such as the reaction with in situ generated benzyne to give 2,4,6-triphenylphosphabarrelene. The corresponding 2,4,6-triphenylphosphabarrelene-selenide could be characterized crystallographically for the first time and the structural and electronic properties of this cage-compound in comparison to classical triarylphosphines could be evaluated. Moreover, [(L)W(CO)5)] complexes of both 2,4,6-triphenylphosphinine and 2,4,6-triphenylphosphabarrelene were prepared and characterized by means of X-ray crystallography. This allowed for the first time a direct structural comparison of these related phosphorus compounds, coordinated to the same metal fragment.

17.
Neuropharmacology ; 34(12): 1635-45, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8788961

RESUMEN

The mouse 5-HT2C receptor and its third and fourth (C-terminal) cytoplasmic domain have been expressed as fusion proteins in bacteria. After purification antisera were generated against the fusion proteins. Characterization by immunoblotting using eukaryotic cells expressing the 5-HT2C and 5-HT2A receptors showed that high titer antibodies could be obtained only against the third and fourth cytoplasmic domain but not the entire receptor. Affinity purified antibodies were used to study the location of 5-HT2C receptors in rat and human brain sections. This distribution was compared with the location of 5-HT2C receptor binding sites as determined by [3H]mesulergine, a 5-HT2C receptor radioligand. The antibodies recognized sites in the rat choroid plexus, hippocampus, cerebral cortex, striatum and substantia nigra with a similar distribution as the 5-HT2C binding sites. One antiserum directed against the 5-HT2C receptor C-terminus crossreacted with the human receptor protein in immunoblots. In human brain sections it labelled sites including cerebral cortex, substantia nigra and cerebellum. Our results demonstrate that the antibodies are suitable to identify 5-TH2C receptors in rat and human brain. They visualize a protein distribution which correlates well with the location of the 5-HT2C receptor binding sites as would be expected if affinity states do not influence the binding pattern.


Asunto(s)
Encéfalo/metabolismo , Sueros Inmunes/biosíntesis , Receptores de Serotonina/análisis , Animales , Western Blotting , Encéfalo/anatomía & histología , Células Cultivadas , Escherichia coli , Femenino , Humanos , Inmunohistoquímica , Masculino , Conejos , Ratas , Ratas Wistar , Receptores de Serotonina/inmunología , Proteínas Recombinantes de Fusión/inmunología , Transfección
18.
Neuroscience ; 56(3): 687-93, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8255427

RESUMEN

The lesion of serotonergic neurons (by an intraventricular injection of 5,7-dihydroxytryptamine) potentiated the conditioned place aversion induced by the 5-hydroxytryptamine1C/5-hydroxytryptamine2 antagonist mianserin in rats. This effect was selective for mianserin as the same lesion suppressed the conditioned place aversion induced by the benzodiazepine inverse agonist FG-7142. Previous results had shown the involvement of the 5-hydroxytryptamine1C receptors in the conditioned place aversion induced by mianserin [Rocha et al. (1993) Behav. Pharmac. 4, 101-106]. It was thus of interest to investigate the effect of the lesion on these receptor binding sites. Autoradiographic binding studies showed that the lesion significantly increased the concentration of the 5-hydroxytryptamine1C binding sites in various brain regions, including the amygdala, the hippocampus and the nucleus accumbens. Contrastingly, in these same brain regions, in situ hybridization histochemistry did not reveal an alteration of the level of messenger RNA coding for these receptors. On the one hand, correlating potentiation of the aversive effects of mianserin and increase of 5-hydroxytryptamine1C binding sites in the limbic system represent an interesting step in the comprehension of the molecular and motivational effects of serotonergic drugs. On the other hand, showing a dissociation between the expression of 5-hydroxytryptamine1C receptors and their corresponding messenger RNA, suggest that post-transcriptional mechanisms are involved in the regulation of these receptors.


Asunto(s)
5,7-Dihidroxitriptamina/toxicidad , Química Encefálica/efectos de los fármacos , Condicionamiento Operante/efectos de los fármacos , Mianserina/farmacología , Receptores de Serotonina/efectos de los fármacos , Animales , Antiparkinsonianos , Autorradiografía , Carbolinas/farmacología , Ergolinas , Hibridación in Situ , Masculino , ARN Mensajero/biosíntesis , Ratas , Receptores de GABA-A/efectos de los fármacos , Receptores de Serotonina/biosíntesis , Transcripción Genética/efectos de los fármacos
19.
Brain Res ; 522(2): 342-6, 1990 Jul 09.
Artículo en Inglés | MEDLINE | ID: mdl-1977497

RESUMEN

A marked increase of the endogenous somatostatin has been reported in the striatum in Huntington's chorea by radioimmunoassay and immunohistochemistry. Using quantitative receptor autoradiography we examined the density and distribution of somatostatin receptors in the striatum of 6 patients dying from Huntington's chorea degree 3, in 12 control healthy patients dying without neurological diseases and 7 schizophrenic patients, using the stable somatostatin octapeptide analogue [125I]204-090 as a radioligand. Marked reductions of the density of somatostatin binding sites were observed in the caudate and putamen of all patients with Huntington's chorea. However, these receptors were well preserved in the nucleus accumbens and in the ventral aspects of the anterior putamen. No alteration of somatostatin receptors was observed in other brain areas. These results suggest that somatostatin receptors in the human striatum are markedly down-regulated or localized on a population of neurons which is at risk in Huntington's chorea and questions the postulated role for the elevated somatostatin levels in choreiform movements.


Asunto(s)
Cuerpo Estriado/metabolismo , Enfermedad de Huntington/metabolismo , Receptores de Neurotransmisores/análisis , Somatostatina , Adulto , Anciano , Anciano de 80 o más Años , Autorradiografía , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Radioinmunoensayo , Receptores de Somatostatina , Esquizofrenia/metabolismo
20.
Eur J Pharmacol ; 262(1-2): 125-31, 1994 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-7813563

RESUMEN

Rats were chronically treated with mianserin (10 mg/kg i.p.) or eltoprazine (1 mg/kg i.p.) and were tested in the elevated plus-maze test for anxiety. 5-HT2C (previously 5-HT1C, see Humphrey et al., 1993, Trends Pharmacol. Sci. 14, 223) binding sites and their mRNA were evaluated in limbic structures (i.e., amygdala, hippocampus, septum) of a sample of these rats by autoradiographic binding studies and in situ hybridization histochemistry. Mianserin and eltoprazine displayed opposite effects in the elevated plus-maze: mianserin induced anxiolytic-like effects, while eltoprazine showed anxiogenic-like ones. Within the amygdala, but not in other structures, the quantitative autoradiographic analysis of the 5-HT2C binding sites showed a differential effect: mianserin treatment induced a decrease in the number of these sites, while eltoprazine treatment resulted in an increase. In spite of this, neither mianserin- nor eltoprazine-treated rats displayed an alteration in the 5-HT2C receptor mRNA levels in the brain regions examined. Our results are suggestive of a relation between anxiolytic/anxiogenic-like effects and the level of 5-HT2C binding sites in the amygdala.


Asunto(s)
Ansiedad/tratamiento farmacológico , Mianserina/farmacología , Piperazinas/farmacología , Receptores de Serotonina/efectos de los fármacos , Agonistas de Receptores de Serotonina/farmacología , Acetilcolinesterasa/metabolismo , Amígdala del Cerebelo/efectos de los fármacos , Amígdala del Cerebelo/enzimología , Amígdala del Cerebelo/metabolismo , Animales , Ansiedad/inducido químicamente , Autorradiografía , Conducta Animal/efectos de los fármacos , Sitios de Unión , Secciones por Congelación , Hipocampo/efectos de los fármacos , Hipocampo/enzimología , Hipocampo/metabolismo , Histocitoquímica , Hibridación in Situ , Inyecciones Intraperitoneales , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Mianserina/administración & dosificación , Mianserina/uso terapéutico , Piperazinas/administración & dosificación , Piperazinas/efectos adversos , ARN Mensajero/metabolismo , Ratas , Receptor de Serotonina 5-HT2C , Receptores de Serotonina/metabolismo , Núcleos Septales/efectos de los fármacos , Núcleos Septales/enzimología , Núcleos Septales/metabolismo , Agonistas de Receptores de Serotonina/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA